Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Revenue (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Serina Therapeutics (SER) Leases (2019 - 2025)

Serina Therapeutics' Leases history spans 5 years, with the latest figure at $88000.0 for Q3 2025.

  • On a quarterly basis, Leases fell 4.35% to $88000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $88000.0, a 4.35% decrease, with the full-year FY2024 number at $461000.0, up 319.09% from a year prior.
  • Leases hit $88000.0 in Q3 2025 for Serina Therapeutics, down from $362000.0 in the prior quarter.
  • Over the last five years, Leases for SER hit a ceiling of $627000.0 in Q1 2024 and a floor of $88000.0 in Q3 2025.
  • Historically, Leases has averaged $339250.0 across 3 years, with a median of $387000.0 in 2025.
  • Biggest five-year swings in Leases: soared 319.09% in 2024 and later crashed 35.59% in 2025.
  • Tracing SER's Leases over 3 years: stood at $110000.0 in 2023, then soared by 319.09% to $461000.0 in 2024, then tumbled by 80.91% to $88000.0 in 2025.
  • Business Quant data shows Leases for SER at $88000.0 in Q3 2025, $362000.0 in Q2 2025, and $412000.0 in Q1 2025.